Yale Cancer Biology Institute
The Yale Cancer Biology Institute connects scientists from across Yale to study the common underlying causes of cancer, wherever it appears. Traditional cancer research continues to focus on vital questions about the treatment and care of specific types of cancer. Complementing this work, today’s research also seeks to understand core cellular and molecular links across multiple cancers. The purpose of the Cancer Biology Institute is to study this core biology.
Yale Cancer Biology Institute
Meet the labs of the Yale Cancer Biology Institute
-
Alarcón Lab
RNA metabolism
-
Ferguson Lab
Extracellular control
-
Kabeche Lab
Genome instability
-
Klein Lab
Signaling transduction
-
LaMarche Lab
Cancer immunology
-
Lemmon Lab
Transmembrane signaling
-
Liu Lab
Proteomics
-
Muzumdar Lab
Genetic adaptations
-
Schlessinger Lab
Growth factor receptors
YCBI News
-
Yale scientists decode chemical transmitter for clues to new cancer therapies
Yale Cancer Biology Institute scientists have redefined the role of a unique chemical receptor, opening the way for new targeted cancer therapies
-
Lilian Kabeche recognized for excellence in research by an Historically Excluded Person
The award is presented to early-career scientists who self-identify as Historically Excluded Persons
-
Daryl Klein takes first place at Yale Life Science Pitchfest
The Associate Professor of Pharmacology was awarded for his project: Rosevix (Rosziqumab) A ROS1 Biologic for Invasive Cancers
